Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Q&A: Medtronic India Head On Industry Challenges And Devices’ Future

This article was originally published in PharmAsia News

Executive Summary

Medtronic India managing director and vice-president South Asia Milind Shah has done in the Indian medical devices industry what his peers in the drug industry are trying hard to emulate. A few years ago Medtronic kicked off a hitherto unknown disruptive financing model that made high-quality stents affordable to needy Indian patients while largely keeping intact the financial goals of the company.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts